UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis

NYSE:UHS • US9139031002

206.42 USD
+0.32 (+0.16%)
At close: Mar 2, 2026
206.42 USD
0 (0%)
After Hours: 3/2/2026, 8:04:00 PM
Fundamental Rating

6

Overall UHS gets a fundamental rating of 6 out of 10. We evaluated UHS against 101 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make UHS suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year UHS was profitable.
  • UHS had a positive operating cash flow in the past year.
  • Each year in the past 5 years UHS has been profitable.
  • Each year in the past 5 years UHS had a positive operating cash flow.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • UHS has a Return On Assets of 9.59%. This is amongst the best in the industry. UHS outperforms 93.07% of its industry peers.
  • Looking at the Return On Equity, with a value of 20.46%, UHS belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 12.52%, UHS belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
  • UHS had an Average Return On Invested Capital over the past 3 years of 10.23%. This is in line with the industry average of 9.12%.
  • The last Return On Invested Capital (12.52%) for UHS is above the 3 year average (10.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROIC 12.52%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • UHS has a better Profit Margin (8.57%) than 90.10% of its industry peers.
  • In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
  • UHS has a Operating Margin of 11.48%. This is amongst the best in the industry. UHS outperforms 81.19% of its industry peers.
  • UHS's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.48%
PM (TTM) 8.57%
GM N/A
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UHS is still creating some value.
  • UHS has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, UHS has less shares outstanding
  • The debt/assets ratio for UHS has been reduced compared to a year ago.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 3.14 indicates that UHS is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.14, UHS is in the better half of the industry, outperforming 67.33% of the companies in the same industry.
  • UHS has a debt to FCF ratio of 5.60. This is a neutral value as UHS would need 5.60 years to pay back of all of its debts.
  • UHS has a Debt to FCF ratio of 5.60. This is in the better half of the industry: UHS outperforms 60.40% of its industry peers.
  • A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.55, UHS is in the better half of the industry, outperforming 61.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Altman-Z 3.14
ROIC/WACC1.68
WACC7.44%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that UHS should not have too much problems paying its short term obligations.
  • UHS has a Current ratio of 1.05. This is in the lower half of the industry: UHS underperforms 63.37% of its industry peers.
  • UHS has a Quick Ratio of 1.05. This is a bad value and indicates that UHS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.98, UHS is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.98
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.77% over the past year.
  • The Earnings Per Share has been growing by 14.35% on average over the past years. This is quite good.
  • UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.71%.
  • The Revenue has been growing by 8.48% on average over the past years. This is quite good.
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%

3.2 Future

  • Based on estimates for the next years, UHS will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.25% on average per year.
  • Based on estimates for the next years, UHS will show a small growth in Revenue. The Revenue will grow by 3.51% on average per year.
EPS Next Y9.16%
EPS Next 2Y10.4%
EPS Next 3Y9.72%
EPS Next 5Y10.25%
Revenue Next Year4.96%
Revenue Next 2Y5.09%
Revenue Next 3Y3.5%
Revenue Next 5Y3.51%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.49, the valuation of UHS can be described as very reasonable.
  • 95.05% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, UHS is valued rather cheaply.
  • A Price/Forward Earnings ratio of 8.69 indicates a reasonable valuation of UHS.
  • 94.06% of the companies in the same industry are more expensive than UHS, based on the Price/Forward Earnings ratio.
  • UHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.49
Fwd PE 8.69
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 87.13% of the companies in the same industry are more expensive than UHS, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UHS indicates a somewhat cheap valuation: UHS is cheaper than 77.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.19
EV/EBITDA 6.69
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of UHS may justify a higher PE ratio.
PEG (NY)1.04
PEG (5Y)0.66
EPS Next 2Y10.4%
EPS Next 3Y9.72%

5

5. Dividend

5.1 Amount

  • UHS has a yearly dividend return of 0.39%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.48, UHS pays a better dividend. On top of this UHS pays more dividend than 80.20% of the companies listed in the same industry.
  • With a Dividend Yield of 0.39, UHS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

  • The dividend of UHS is nicely growing with an annual growth rate of 32.23%!
  • UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)32.23%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • UHS pays out 3.44% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of UHS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP3.44%
EPS Next 2Y10.4%
EPS Next 3Y9.72%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (3/2/2026, 8:04:00 PM)

After market: 206.42 0 (0%)

206.42

+0.32 (+0.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-27
Inst Owners98.09%
Inst Owner Change-1.66%
Ins Owners5.68%
Ins Owner Change2.62%
Market Cap12.90B
Revenue(TTM)17.36B
Net Income(TTM)1.49B
Analysts70.37
Price Target252.08 (22.12%)
Short Float %3.87%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend0.81
Dividend Growth(5Y)32.23%
DP3.44%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-1.33%
Max EPS beat(2)16.52%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-1.33%
Max EPS beat(4)16.52%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)11
Avg EPS beat(12)9.91%
EPS beat(16)13
Avg EPS beat(16)6.42%
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)2.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)8
Avg Revenue beat(12)0.15%
Revenue beat(16)12
Avg Revenue beat(16)0.29%
PT rev (1m)-0.95%
PT rev (3m)1.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)0%
EPS NY rev (3m)2.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 9.49
Fwd PE 8.69
P/S 0.74
P/FCF 15.19
P/OCF 6.92
P/B 1.77
P/tB 3.93
EV/EBITDA 6.69
EPS(TTM)21.76
EY10.54%
EPS(NY)23.75
Fwd EY11.51%
FCF(TTM)13.59
FCFY6.58%
OCF(TTM)29.84
OCFY14.46%
SpS277.93
BVpS116.45
TBVpS52.59
PEG (NY)1.04
PEG (5Y)0.66
Graham Number238.78
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROCE 16.23%
ROIC 12.52%
ROICexc 12.66%
ROICexgc 18.85%
OM 11.48%
PM (TTM) 8.57%
GM N/A
FCFM 4.89%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
ROICexc(3y)10.34%
ROICexc(5y)9.46%
ROICexgc(3y)15.38%
ROICexgc(5y)14.27%
ROCE(3y)13.26%
ROCE(5y)12.14%
ROICexgc growth 3Y22.6%
ROICexgc growth 5Y1.17%
ROICexc growth 3Y23.35%
ROICexc growth 5Y3.38%
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Debt/EBITDA 1.53
Cap/Depr 164.07%
Cap/Sales 5.85%
Interest Coverage 12.78
Cash Conversion 71.36%
Profit Quality 57.04%
Current Ratio 1.05
Quick Ratio 0.98
Altman-Z 3.14
F-Score8
WACC7.44%
ROIC/WACC1.68
Cap/Depr(3y)152.09%
Cap/Depr(5y)148.58%
Cap/Sales(3y)5.67%
Cap/Sales(5y)5.85%
Profit Quality(3y)76.18%
Profit Quality(5y)54.04%
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
EPS Next Y9.16%
EPS Next 2Y10.4%
EPS Next 3Y9.72%
EPS Next 5Y10.25%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%
Revenue Next Year4.96%
Revenue Next 2Y5.09%
Revenue Next 3Y3.5%
Revenue Next 5Y3.51%
EBIT growth 1Y18.56%
EBIT growth 3Y25.72%
EBIT growth 5Y7.99%
EBIT Next Year33.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.4%
FCF growth 3Y47.99%
FCF growth 5Y-12.18%
OCF growth 1Y-9.81%
OCF growth 3Y23.24%
OCF growth 5Y-4.61%

UNIVERSAL HEALTH SERVICES-B / UHS FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 7 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.


How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.44%.